Suprefort
- Category
- Bioregulators
- Administration routes
- Oral
- Regulatory status
- Not FDA-approved
What it is
Suprefort is a bioregulator peptide from pancreatic tissue, marketed to support pancreatic function in aging. Its best claim, glucose stabilization in early diabetes, rests on weak human data; digestive claims have limited observational support, while normalization of pancreatic function remains unproven. Main risks are a low chance of allergic reaction (bovine origin) and interaction with diabetes medications. It is not FDA-approved, and available products are unregulated.
Read Full recordStudied uses & evidence
Studied uses(3)
Improved digestive function in chronic pancreatitis
LowA small 12-patient Khavinson Institute trial found modest enzyme gains; not peer-reviewed or independently confirmed.
Glucose level stabilization in latent type 2 diabetes
LowA small, unpublished institute study found glucose improvement in latent type 2 diabetics taking Suprefort.
Normalization of pancreatic exocrine and endocrine function
LowOne small open-label Khavinson trial found eased pancreatitis symptoms and a glucose-trend improvement.
Evidence limits
- Evidence Level
- Very Limited Evidence
One formal clinical study from the Khavinson Institute tested Suprefort in 34 patients over 15 days. Results were modest but positive for both pancreatitis and diabetes subgroups. The study was open-label, single-center, and small. No independent replication exists.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(2)
Risks = level of concern: High · Moderate · Low · Theoretical
Allergic reaction to bovine pancreas-derived peptides
LowPotential interaction with diabetes medications
Moderate
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.